Strzelec, M.; Kubicka, E.; Kuliczkowska-Płaksej, J.; Kolačkov, K.; Janek, Ł.; Bolanowski, M.; Jawiarczyk-Przybyłowska, A.
Copeptin and Mid-Regional Proadrenomedullin Are Not Useful Biomarkers of Cardiometabolic Disease in Patients with Acromegaly—A Preliminary Study. Biomedicines 2025, 13, 666.
https://doi.org/10.3390/biomedicines13030666
AMA Style
Strzelec M, Kubicka E, Kuliczkowska-Płaksej J, Kolačkov K, Janek Ł, Bolanowski M, Jawiarczyk-Przybyłowska A.
Copeptin and Mid-Regional Proadrenomedullin Are Not Useful Biomarkers of Cardiometabolic Disease in Patients with Acromegaly—A Preliminary Study. Biomedicines. 2025; 13(3):666.
https://doi.org/10.3390/biomedicines13030666
Chicago/Turabian Style
Strzelec, Martyna, Eliza Kubicka, Justyna Kuliczkowska-Płaksej, Katarzyna Kolačkov, Łucja Janek, Marek Bolanowski, and Aleksandra Jawiarczyk-Przybyłowska.
2025. "Copeptin and Mid-Regional Proadrenomedullin Are Not Useful Biomarkers of Cardiometabolic Disease in Patients with Acromegaly—A Preliminary Study" Biomedicines 13, no. 3: 666.
https://doi.org/10.3390/biomedicines13030666
APA Style
Strzelec, M., Kubicka, E., Kuliczkowska-Płaksej, J., Kolačkov, K., Janek, Ł., Bolanowski, M., & Jawiarczyk-Przybyłowska, A.
(2025). Copeptin and Mid-Regional Proadrenomedullin Are Not Useful Biomarkers of Cardiometabolic Disease in Patients with Acromegaly—A Preliminary Study. Biomedicines, 13(3), 666.
https://doi.org/10.3390/biomedicines13030666